CIK: 1413525 - Address: C/O Dyadic International, Inc., 1044 North U.S. Highway One, Suite 201, Jupiter, FL 33477-5094
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret115134426337225073
P%wins60806040604057

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/25/24 11:59
11/22/24
DYAIDyadic International IncDEHealthBioPrdBiological Products, (No DiagTarnok Michael P.FLDM.d240.970002511247D
5/23/24 15:42
5/21/24
DYAIDyadic International IncDEHealthBioPrdBiological Products, (No DiagTarnok Michael P.FLDM.d411.3603016222D
1/4/24 20:01
1/3/24
DYAIDyadic International IncDEHealthBioPrdBiological Products, (No DiagTarnok Michael P.FLDM.d00.0002714216D
5/6/15 16:01
5/6/15
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTarnok Michael P.NYDP979.7318103329D28-29-39-15-26-17-10-3-233-25-49-46
4/9/12 09:01
4/5/12
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTarnok Michael P.NYDP271.5515187279D-54-71-48-40-50-65-67-9-8-8-102372424
8/11/11 07:36
8/10/11
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTarnok Michael P.NYDP473.105156261D134-23-24-41-35-38-35-1483129-810-37
5/27/09 12:14
5/26/09
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTarnok Michael P.NYDP180.460014026191D-96-42141931207622664193109207423999
11/20/07 16:40
11/19/07
KERXKeryx Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTarnok Michael P.NYDP108.7141New1D-41-37-18-16-18-14-7-540-1-34-95-99

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact